• Joseph L. Pace


The Maltese Islands lie in the center of the Mediterranean Sea some 60 miles from Sicily and 180 miles from North Africa. The population is around 360,000, almost uniformly of southern European extraction. The climate is mild with most people leading an “outdoor” life as much as possible between June and September. The major industry is tourism, and the population increases dramatically in the summer months, straining severely the islands’ infrastructure. Winter tourism is also popular. Malta has established itself as a center for teaching English, and large numbers of students of all ages attend the numerous language schools. In addition, large numbers of Maltese regularly return home on long visits from their adopted countries of Australia, Canada, and the United States.


Herpes Zoster Visceral Leishmaniasis Cutaneous Leishmaniasis Severe Acne Lepromatous Leprosy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Tsankor, NK: Kamarasher, JA: Rofampin in dermatology. Int J Dermatol 1993; 32: 401–406.CrossRefGoogle Scholar
  2. 2.
    Pace JL: Rifampicin in cutaneous leishmaniasis. Arch Dermatol 1982; 118: 880.Google Scholar
  3. 3.
    Freerksen E, Depasquale G: In: Freerksen E, ed. The Malta Project-A Leprosy Eradication Programme. German Leprosy Relief Association, 1987.Google Scholar
  4. 4.
    Noordeen SK: Recent status of leprosy in the world, and WHO’s approach to the problem. International Seminar on Leprosy, Istanbul, September 1991.Google Scholar
  5. 5.
    Cohen LE, McNeill CJ, Wells RF: Clindamycin associated colitis. JA MA 1973; 223: 1379–1380.Google Scholar
  6. 6.
    Gurwith MJ, Rabin HR, Love K: Diarrhea associated with clindamycin and ampicillin. J Infect Dis 1977; 135 (suppl): 104–110.CrossRefGoogle Scholar
  7. 7.
    Claussen CF, Schneider D, Claussen E: Equilibriometric measurements of central vestibular dysregulation following administration minocycline. Artzneimittelforschung 1987; 37: 950–953.Google Scholar
  8. 8.
    Lubvetski C: Hypertension intracranienne bengin et minocycline. Rev Neural (Paris) 1988; 144: 218.Google Scholar
  9. 9.
    Wolfe, ID, Reichrnister J, Minocycline hyperpigmentation skin: tooth, nail and bone involvement. Curtis 1984; 33: 457–458.Google Scholar
  10. 10.
    Sammut A: Systemtic treatment of acne with special reference to clindamycin. Thesis. University of Malta, 1990: 43–69.Google Scholar
  11. 1l.
    Ad Hoc Committee on the Use of Antibiotics in Dermatology: Systemic antibiotics for treatment of acne vulgaris-efficacy and safety. Arch Dermatol 1975; 111: 1630–1636.CrossRefGoogle Scholar
  12. 12.
    Pace JL: Fixed drug eruptions in Saudi Arabia. Saudi Med J 1984; 5: 315–318.Google Scholar
  13. 13.
    Pace JL, Gatt P: Fatal vasculitis with ofloxacin. BMJ 1989; 299: 658.PubMedCrossRefGoogle Scholar
  14. 14.
    Scerri L, Pace JL: Mefloquin associated cutaneous vasculitis. In t J Dermatol 1993; 32: 517–518.Google Scholar
  15. 15.
    Pace JL, Calnan C, Soler D: In: Panconesi E, ed. Captopril induced pemphigus erythematosus in Dermatology in Europe. Oxford: Blackwell Scientific Publications, 1991: 946–948.Google Scholar
  16. 16.
    Zovirax: in 1994 Physicians Desk Reference. Montvale, NJ. Medical Economics Data Production 1994: 765–772.Google Scholar
  17. 17.
    Pace JL, Csonka GW: Endemic non-venereal syphilis in Arabia. Br J Venereal Dis 1984; 60: 293–297.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1994

Authors and Affiliations

  • Joseph L. Pace

There are no affiliations available

Personalised recommendations